Brandon Cometti, MD
Family Medicine · Roswell, NMNPI 1265792022
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,836 of the $3,355 with a category attached, or 84.5%. 19 manufacturers reported payments, led by Johnson & Johnson at 25.4% of the total. Among family medicine clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$852
- AbbVie$760
- Regeneron Healthcare Solutions, Inc.$278
- E.r. Squibb & Sons, L.L.C.$277
- Lilly USA, LLC$239
- Incyte Corporation$202
- plus $747 from 13 others
What the payments were for
- Food & beverage$2,83685%
- Education$51915%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 29 | $852 |
| AbbVie | 37 | $760 |
| Regeneron Healthcare Solutions, Inc. | 12 | $278 |
| E.r. Squibb & Sons, L.L.C. | 17 | $277 |
| Lilly USA, LLC | 13 | $239 |
| Incyte Corporation | 7 | $202 |
| Amgen | 8 | $186 |
| Galderma Laboratories, L.p. | 6 | $104 |
| Merz North America, Inc. | 5 | $97 |
| Sanofi | 4 | $84 |
| Novartis | 3 | $53 |
| Pfizer | 3 | $41 |
| Sandoz | 2 | $39 |
| Organon | 1 | $33 |
| Krystal Biotech Inc | 1 | $31 |
| UCB, Inc. | 1 | $27 |
| Boehringer Ingelheim | 1 | $24 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Fresenius Kabi USA, LLC | 1 | $14 |
How this compares
$3,355 in reported general payments places this provider in the 90th percentile of 717 family medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 41 | $874,003 |
| Humira(Cf) PenAdalimumab | 36 | $468,362 |
| Dupixent PenDupilumab | 73 | $332,327 |
| Taltz AutoinjectorIxekizumab | 18 | $126,944 |
| RinvoqUpadacitinib | 12 | $116,460 |
| OtezlaApremilast | 23 | $116,174 |
| Clobetasol Propionate | 111 | $4,759 |
| Triamcinolone Acetonide | 259 | $3,632 |
| MethotrexateMethotrexate Sodium | 118 | $3,334 |
| Fluorouracil | 50 | $2,839 |
| Metronidazole | 43 | $2,185 |
| Minocycline Hcl | 101 | $2,031 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 37 | $1,760 |
| Ketoconazole | 85 | $1,542 |
| Mycophenolate Mofetil | 16 | $1,370 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $760 | $116,46012 claims |
| AmgenOtezla | $186 | $116,17423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 717 family medicine providers in New Mexico.
Other family medicine in Roswell
- Richard PinonRoswell$4K
- Harold McFarlingFarmington$160K
- Carletta BullockAlbuquerque$60K
- Robert BairAlbuquerque$44K
- Wendy JohnsonSanta Fe$37K
- Delliah StamppLas Cruces$21K
- Conchita PazLas Cruces$16K
- Sergio HuertaLas Cruces$11K
- Timothy GrenemyerAlbuquerque$10K
- Cheri BlackstenAlbuquerque$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.